It is a pharma private limited company based in Mumbai, Maharashtra, India, established in 2009.
2009 | Mumbai, Maharashtra, India | Struck OffOnkology Kombine Private Limited, a struck off private limited company, was established on 06 August 2009 in Mumbai, Maharashtra, India. Engaging in drug formulation & development within the pharma sector, it holds CIN: U24100MH2009PTC194712. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.
Formerly known as Zen Oncology Private Limited. It upholds a compliant status. Its leadership includes Yogesh Parikh Navnitlal (Director), Mehul Parekh Jayant (Director). Past directors included Dewashish Prasad Shrivastava, Sameer Kaul, Sandip Jayant Parekh. Its latest AGM occurred on 30 September 2022, with the balance sheet filed on 31 March 2022. It is based at E/501, Sky Park Chs Ltd, Oshiwara Garden Road, Next To Hdfc House, Off. S.V.Road, Goreg, Aon - West, Mumbai, Maharashtra, 400104.
U24100MH2009PTC194712
194712
06 August 2009
₹0.10 M
₹0.10 M
Roc Mumbai
Unlisted
Struck Off
Explore comprehensive insights into Onkology Kombine Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Yogesh Parikh Navnitlal | Director | 06 Aug 2009 | Current |
| Mehul Parekh Jayant | Director | 06 Aug 2009 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 06 Aug 2018 | Past |
| Pramod Abcsdd | Director | 16 Jan 2012 | Past |
| Pramod Abcsdd | Director | 03 Feb 2020 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Onkology Kombine Private Limited, for the financial year ended 2021, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
In 2021, Onkology Kombine had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Onkology Kombine, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Onkology Kombine, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Onkology Kombine's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Onkology Kombine Private Limited last Annual general meeting of members was held on 30 Sep 2022 as per latest MCA records. was completed.
Progress on Onkology Kombine Private Limited has filed its annual Financial statements for the year ended 31 Mar 2022 with Roc Mumbai. was documented.
Progress on Yogesh Parikh Navnitlal was appointed as a Director was appointed as a Director on 06 Aug 2009 & has been associated with this company since 16 years 3 months . was documented.
The activity Mehul Parekh Jayant was appointed as a Director was appointed as a Director on 06 Aug 2009 & has been associated with this company since 16 years 3 months . was completed.
Progress on Onkology Kombine Private Limited was registered on 06 Aug 2009 with Roc Mumbai & aged 16 years 3 months as per MCA records. was documented.
The CIN of Onkology Kombine Private Limited is U24100MH2009PTC194712.
Onkology Kombine Private Limited is headquartered at E/501, Sky Park Chs Ltd, Oshiwara Garden Road, Next To Hdfc House, Off. S.V.Road, Goreg, Aon - West, Mumbai, Maharashtra, 400104.
Onkology Kombine Private Limited was incorporated on 06 August 2009.
The current directors of Onkology Kombine Private Limited are
The primary industry of Onkology Kombine Private Limited is Pharma.
Onkology Kombine Private Limited is unlisted.
The authorized capital of Onkology Kombine Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.
The compliance status of Onkology Kombine Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX